Arkolith/Insider Trading/AGLE/Form 4

Quinn Anthony G.

President & CEO, DirectorAeglea BioTherapeutics, Inc. (AGLE) · full profile →Form 4 · filed Mar 15, 2022
Net Buying
Open-Market Buys
$281K
Open-Market Sells
$0
Net Open-Market Flow
$281K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 15, 2022Buy(P)42K$1.86$79K473K
Mar 14, 2022Buy(P)67K$1.93$130K431K
Mar 11, 2022Buy(P)35K$2.06$72K364K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-018942) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML